| 2/19/2016 | BKHYIG | S&P lifts Quintiles, loans, notes
|
| 5/7/2015 | CLHY | Market Commentary: TTM Technologies, Chemours, Leighton, Quintiles, eResearch, Black Knight free to trade
|
| 5/5/2015 | CLHY | Market Commentary: Prestige, Hyland, W&T Offshore break; Chemours, J. Jill, eResearch, Quintiles reworked
|
| 5/1/2015 | BKHY | S&P rates Quintiles facility BB+, notes BB
|
| 5/1/2015 | BKHY | Moody’s ups Quintiles, rates loans Ba1, notes Ba3
|
| 4/29/2015 | CLHY | Market Commentary: Horizon Pharma breaks; Avaya updated; Script Relief, Air Canada, Sensata, Veresen launch
|
| 12/10/2014 | BKHYIG | S&P lifts Quintiles, rates new loan BBB
|
| 11/21/2013 | BKHY | S&P upgrades Quintiles
|
| 12/11/2012 | BKHY | S&P rates Quintiles loan BB-
|
| 10/12/2012 | BKHY | Moody's rates Quintiles loans B1
|
| 10/10/2012 | BKHY | S&P rates Quintiles loan BB-
|
| 2/22/2012 | BKHY | S&P rates Quintiles loan B
|
| 2/22/2012 | BKHY | Moody's: Quintiles loan B3
|
| 5/13/2011 | BKHY | S&P rates Quintiles loan BB-
|
| 5/12/2011 | BKHY | Moody's: Quintiles loan B1
|
| 3/11/2011 | BKHY | Moody's: Quintiles loan at B1
|
| 1/21/2009 | BKHY | S&P ups Quintiles debt to B+
|
| 12/21/2007 | BKHY | S&P affirms Quintiles
|
| 9/21/2006 | BKBTCVHY | Moody's revises ratings for nine U.S. pharma companies
|
| 3/31/2006 | HY | Quintiles buys back 99.2% of 10% notes, all of 111/2% discount notes in tender offer
|
| 3/17/2006 | HY | Quintiles receives consents to amend indentures of 10% notes, 111/2% discount notes
|
| 3/7/2006 | BKBTHY | Moody's rates Quintiles loans B1, B3
|
| 3/6/2006 | BTHY | Quintiles tenders for 10% notes due 2013, 111/2% notes due 2014
|
| 3/6/2006 | BKBTHY | S&P rates Quintiles loans BB-, B
|
| 12/9/2005 | BKBTHY | Moody's affirms Quintiles
|
| 10/28/2005 | BKBTHY | S&P ups Quintiles view to positive
|
| 10/21/2005 | BKBTHY | Quintiles completes Duloxetine royalty deal, sells $125 million bonds, obtains $125 million loan
|
| 6/9/2004 | BKHY | S&P: Quintiles unaffected
|
| 9/26/2003 | BKHY | Moody's raises Scotts outlook, liquidity, rates notes Ba3, loan Ba1
|
| 9/15/2003 | HY | Market Commentary: Levi gains on probe results announcement; Perry Ellis, Buckeye Technologies price deals
|
| 9/12/2003 | BKHY | Moody's confirms Pharma Services
|
| 9/12/2003 | HY | New Issue: Quintiles $450 million 10-year notes yield 10%
|
| 9/12/2003 | HY | Market Commentary: Dobson, Pathmark price deals; secondary largely ignores outflow number
|
| 9/10/2003 | HY | Market Commentary: Levi bonds firm, then fall; Seminis hitting road with $190 million deal
|
| 9/10/2003 | BKHY | S&P cuts Levi Strauss
|
| 9/10/2003 | HY | Quintiles/Pharma Services $450 million 10-year notes talked at 91/2%, pricing Friday
|
| 8/27/2003 | HY | Quintiles starts roadshow for $450 million 10-year notes on Sept. 3
|
| 8/27/2003 | HY | Market Commentary: Qwest gains on upgrade possibility; Quintiles to roadshow 10-year deal after holiday
|
| 8/26/2003 | HY | Market Commentary: WorldCom gains on likelihood of bankruptcy emergence; AmericCredit up on results
|
| 6/11/2003 | HY | Citigroup to be bookrunner on $450 million notes for Quintiles LBO
|
| 6/11/2003 | HY | Market Commentary: Xerox bonds up on recapitalization news; MSW Energy prices seven-year deal
|
| 6/10/2003 | BKHY | S&P rates Gerdau Ameristeel notes B+, loan BB
|
| 6/9/2003 | BKHY | S&P keeps TransDigm on watch
|
| 4/28/2003 | BKHY | Quintiles looking at $425 million loan, $450 million bonds for debt package
|
| 4/11/2003 | BKHY | Pharma Services obtains $875 million debt commitments for Quintiles acquisition
|
| 4/11/2003 | BKHY | Moody's lowers Smithfield outlook
|
| 2/21/2002 | HY | Moody's cuts Energis
|
